Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Galectins | 11 | 2024 | 295 | 2.590 |
Why?
|
ABO Blood-Group System | 4 | 2024 | 381 | 1.030 |
Why?
|
Galectin 1 | 3 | 2022 | 128 | 0.870 |
Why?
|
Carbohydrates | 2 | 2022 | 389 | 0.670 |
Why?
|
Anti-Infective Agents | 3 | 2024 | 983 | 0.650 |
Why?
|
Oligosaccharides | 1 | 2021 | 407 | 0.630 |
Why?
|
Streptococcus pneumoniae | 1 | 2023 | 764 | 0.570 |
Why?
|
Galectin 4 | 2 | 2024 | 36 | 0.410 |
Why?
|
Blood Group Antigens | 3 | 2024 | 183 | 0.400 |
Why?
|
Alkylation | 2 | 2022 | 84 | 0.380 |
Why?
|
Galactosides | 2 | 2016 | 54 | 0.260 |
Why?
|
Isoantibodies | 3 | 2024 | 681 | 0.250 |
Why?
|
Erythroblastosis, Fetal | 1 | 2023 | 62 | 0.210 |
Why?
|
Chromatography, Affinity | 2 | 2022 | 525 | 0.210 |
Why?
|
Galactose | 2 | 2022 | 300 | 0.210 |
Why?
|
Iodoacetamide | 1 | 2022 | 33 | 0.200 |
Why?
|
Galectin 2 | 1 | 2022 | 13 | 0.200 |
Why?
|
Oligosaccharides, Branched-Chain | 1 | 2021 | 5 | 0.190 |
Why?
|
Carbohydrate Conformation | 1 | 2021 | 206 | 0.180 |
Why?
|
Convalescence | 1 | 2021 | 107 | 0.180 |
Why?
|
Carbohydrate Sequence | 1 | 2021 | 411 | 0.180 |
Why?
|
Consensus Sequence | 1 | 2021 | 363 | 0.180 |
Why?
|
Sialic Acids | 1 | 2020 | 123 | 0.180 |
Why?
|
Erythrocyte Membrane | 1 | 2021 | 438 | 0.160 |
Why?
|
Polysaccharides | 2 | 2023 | 1024 | 0.160 |
Why?
|
Serotonin | 2 | 2014 | 1043 | 0.160 |
Why?
|
Erythrocyte Transfusion | 1 | 2023 | 575 | 0.150 |
Why?
|
Protein Binding | 5 | 2024 | 9343 | 0.150 |
Why?
|
Immunoglobulin A | 1 | 2021 | 992 | 0.140 |
Why?
|
Erythrocytes | 2 | 2023 | 2418 | 0.140 |
Why?
|
Substrate Specificity | 1 | 2021 | 1751 | 0.140 |
Why?
|
Galectin 3 | 2 | 2016 | 240 | 0.140 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2021 | 2748 | 0.140 |
Why?
|
Sequence Alignment | 1 | 2021 | 2179 | 0.130 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2202 | 0.130 |
Why?
|
Organ Specificity | 1 | 2021 | 1968 | 0.130 |
Why?
|
Immunity, Innate | 2 | 2024 | 3080 | 0.120 |
Why?
|
Triazoles | 1 | 2020 | 904 | 0.120 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1065 | 0.120 |
Why?
|
Disaccharides | 1 | 2015 | 170 | 0.120 |
Why?
|
Molecular Mimicry | 2 | 2024 | 213 | 0.100 |
Why?
|
Transglutaminases | 1 | 2013 | 200 | 0.100 |
Why?
|
Isoantigens | 2 | 2023 | 562 | 0.090 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3214 | 0.090 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13422 | 0.080 |
Why?
|
Immunization, Passive | 2 | 2021 | 619 | 0.080 |
Why?
|
ras Proteins | 1 | 2013 | 1058 | 0.070 |
Why?
|
Immunoglobulin M | 2 | 2021 | 1528 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1966 | 0.060 |
Why?
|
Rho(D) Immune Globulin | 1 | 2023 | 34 | 0.060 |
Why?
|
Humans | 17 | 2024 | 768171 | 0.060 |
Why?
|
Nucleocapsid | 1 | 2022 | 62 | 0.050 |
Why?
|
Ligands | 2 | 2020 | 3284 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2016 | 1951 | 0.050 |
Why?
|
Proteomics | 1 | 2014 | 3912 | 0.040 |
Why?
|
Blood Proteins | 2 | 2016 | 1191 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4568 | 0.040 |
Why?
|
Heart Septal Defects | 1 | 2021 | 191 | 0.040 |
Why?
|
Proteins | 1 | 2014 | 6009 | 0.040 |
Why?
|
Serologic Tests | 1 | 2021 | 382 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18065 | 0.040 |
Why?
|
Blood Donors | 1 | 2021 | 343 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2024 | 966 | 0.040 |
Why?
|
Immunization | 1 | 2023 | 1219 | 0.040 |
Why?
|
Antigens | 1 | 2023 | 1443 | 0.040 |
Why?
|
Animals | 4 | 2024 | 169285 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 1003 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2021 | 610 | 0.030 |
Why?
|
Calorimetry | 1 | 2016 | 132 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2022 | 14729 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1135 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2421 | 0.030 |
Why?
|
Thermodynamics | 1 | 2016 | 591 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2023 | 2323 | 0.030 |
Why?
|
Click Chemistry | 1 | 2014 | 101 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3814 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 2009 | 0.030 |
Why?
|
Down Syndrome | 1 | 2021 | 919 | 0.030 |
Why?
|
Escherichia coli | 1 | 2024 | 4213 | 0.020 |
Why?
|
Glutamine | 1 | 2014 | 577 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 505 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1046 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4280 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23648 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3437 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 996 | 0.020 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2016 | 522 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2014 | 1080 | 0.020 |
Why?
|
Kinetics | 1 | 2016 | 6330 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3956 | 0.020 |
Why?
|
Binding Sites | 1 | 2016 | 6019 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3590 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1197 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6512 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5402 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3782 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2023 | 26421 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 81760 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26379 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36535 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 17142 | 0.010 |
Why?
|
Mice | 1 | 2020 | 82049 | 0.010 |
Why?
|
Female | 2 | 2023 | 397187 | 0.010 |
Why?
|
United States | 1 | 2021 | 73039 | 0.010 |
Why?
|
Adult | 1 | 2023 | 223646 | 0.000 |
Why?
|
Concepts
(105)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_